期刊文献+

银丹心脑通抑制泡沫细胞形成及巨噬细胞分泌基质金属蛋白酶 被引量:2

Yindanxinnaotong Inhibited the Formation of Foam Cells and the Secretion of Matrix Metalloproteinase by Macrophages
原文传递
导出
摘要 目的:银丹心脑临床治疗冠心病心绞痛疗效显著,但其机理尚不明确。本实验通过观察银丹心脑通对巨噬细胞分泌基质金属蛋白酶的作用,探讨银丹心脑通的作用机理。方法:生长状态良好的单核细胞分化成巨噬细胞,加入不同浓度的药物。24 h后收集细胞上清,ELISA检测细胞上清中MMP-2、MMP-9的含量。结果:给药组不同剂量均能抑制MMP-2、MMP-9的表达(P<0.01-0.05),其中高剂量组效果最为显著。结论:银丹心脑通能够抑制巨噬细胞基质金属蛋白酶的分泌,具有明显的抗炎作用,此实验为其在临床上的进一步应用提供了依据。 Objective: Yindanxinnaotong capture has significant efficacy on clinical treatment of angina pectoris,but its mechanism is not clear.The aim of the experiment is to explore action mechanism of yindanxinnaotong capture by observing the effect of macrophage secretion of matrix metalloproteinase.Methods: Good growth monocytes were differentiated into macrophages,and then added drugs with different concentrations.Supernatants were collected after 24 h,Elisa was used to detect the content of MMP-2 and MMP-9.Results: Treatment groups with different doses inhibited MMP-2,MMP-9 expression(P 0.01-0.05),in which the high-dose group turned out to have the most significant effect.Conclusion: Yindanxinnaotong can inhabit the secretion of matric metalloproteinase and had a significant anti-inflammatory effect.This experiment provided basis for its clinical application.
出处 《现代生物医学进展》 CAS 2013年第17期3234-3237,共4页 Progress in Modern Biomedicine
关键词 银丹心脑通 巨噬细胞 基质金属蛋白酶 Yindanxinnaotong Macrophage Matrix metalloproteinase
  • 相关文献

参考文献20

  • 1Wagsiiter D, Zhu C, Bjerkegren J, et al. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr( -/- )Apob( 100/100) mouse[J]. Int J Mol Med,2011,28 (2):247-253.
  • 2Phipps JE, Hatami N, Galis ZS. A fluorescence lifetime spectroscopy study of matrix metal1oproteinases-2 and -9 in human atherosclerotic plague[J]. J Biophotonics,2011,4(9):650-658.
  • 3Heo SH, Cho CH, Kim HO. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9[J]. J Clin Neurol,2011 ,7(2):69-76.
  • 4Shevchenko AV, Golovanova OV, Konenkov VI. Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease[J]. Ter Arkh,2010,82(1):3l-34.
  • 5Braunersreuther V, Steffens S, Arnaud C. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice[J]. Arterioscler Thromb Vase Biol,2008,28(6): 1090-1096.
  • 6Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction [J]. Clin Chem, 2008,54(1):24-38.
  • 7Chen KC, Wang YS, Hu CY, et al. OxLDL up-regulates microRNA- 29b, leading to epigenetic modifications of MMP-21 MMP-9 genes: a novel mechanism for cardiovascular diseases [J]. FASEB J,2011,25 (5): 1718-1728.
  • 8Guo H, Shi Y, Liu L. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-de.ficient mice [J]. Arch Med Res,2009,40(5):345-351.
  • 9张丽,张立.银丹心脑通胶囊治疗冠心病心绞痛60例[J].实用中医内科杂志,2009(3). 被引量:4
  • 10石宝连.银丹心脑通胶囊治疗冠心病心绞痛30例[J].中西医结合心脑血管病杂志,2009,7(10):1224-1225. 被引量:6

二级参考文献59

共引文献48

同被引文献42

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部